CWH C1156168

 A

Short answer: yes, glucagon stimulation can carry increased risk in a child with rapid or significant weight loss, and it should be approached cautiously.

Why glucagon stimulation can be risky

The glucagon stimulation test (GST) is commonly used to assess growth hormone (GH) and/or cortisol (ACTH–adrenal axis) function. Glucagon raises blood glucose initially, then causes insulin release, which can lead to delayed hypoglycemia.

In a child with rapid weight loss, several factors increase risk:

1. Limited glycogen stores

   • Weight loss, malnutrition, or eating disorders reduce liver glycogen

   • Glucagon may be less effective at raising glucose → higher risk of hypoglycemia

2. Baseline hypoglycemia risk

   • Underweight or catabolic children are more prone to prolonged or severe hypoglycemia during GST

3. Adrenal insufficiency concern

   • If cortisol deficiency is present, hypoglycemia during the test can be more severe and prolonged

4. Common adverse effects

   • Nausea, vomiting (very common)

   • Headache, abdominal pain

   • Hypotension (less common)

   • Seizures are rare but reported, usually related to hypoglycemia

When extra caution or avoidance is warranted

GST should be reconsidered or delayed if the child has:

• Significant or unexplained rapid weight loss

• Suspected eating disorder or malnutrition

• Recurrent hypoglycemia

• Intercurrent illness

• Known or suspected adrenal insufficiency without steroid coverage

Risk mitigation if GST is performed

If clinicians proceed, typical precautions include:

• Testing only in a monitored setting

• Frequent glucose checks (often up to 3–4 hours)

• IV access in place

• Readiness to treat hypoglycemia

• Considering alternative testing strategies when appropriate

Alternatives

Depending on the clinical question, alternatives may include:

• Morning cortisol ± ACTH

• Low-dose ACTH stimulation (often safer for cortisol assessment)

• Deferring GH testing until nutritional status improves

Bottom line

In a child with rapid weight loss, glucagon stimulation is not contraindicated outright, but it does carry higher risk, particularly for hypoglycemia, and should only be done after careful endocrine evaluation with appropriate safeguards.

If you want, I can tailor this further:

• GH vs cortisol testing?

• Degree of weight loss or BMI concerns?

• Age of the child?